News about

Gobivaz, First Simponi Biosimilar, Wins EEA Approval

Gobivaz, First Simponi Biosimilar, Wins EEA Approval

Alvotech, a global biotechnology company focused on biosimilars, and Advanz Pharma, a UK-based pharmaceutical company specializing in specialty and hospital medicines, announced that the European Commission has granted marketing authorizations for Gobivaz, Alvotech’s biosimilar to Simponi (golimumab).

| 23/11/2025 | By 237

ACG Launches DryPod for Moisture-Sensitive Pharmaceutical Blisters

ACG Launches DryPod for Moisture-Sensitive Pharmaceutical Blisters

DryPod by ACG marks an advancement for pharmaceutical manufacturers who have long grappled with limited availability, rigid technologies, and compatibility issues within existing desiccant cold-form solutions.

| 21/11/2025 | By 622

Steriline Marks 100th Installation in India as It Returns to CPHI & PMEC

Steriline Marks 100th Installation in India as It Returns to CPHI & PMEC

With approximately 20 years of activity in the Indian market, Steriline has now reached 100 full line installations and aims for double-digit annual installations in 2026.

| 21/11/2025 | By 150

Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma

Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma

Actimed Therapeutics has entered into an exclusive licensing agreement with Mankind Pharma for S-pindolol, its novel therapy in development for cancer cachexia. The partnership marks a step toward delivering the first globally approved treatment for this debilitating condition to patients across India and South Asia.

| 21/11/2025 | By 161

Solventum to Acquire Acera Surgical for USD 725 Million to Boost Regenerative Wound Care

Solventum to Acquire Acera Surgical for USD 725 Million to Boost Regenerative Wound Care

Solventum, a healthcare company rooted in decades of innovation, announced a definitive agreement to acquire Acera Surgical for $725 million in cash, with an additional $125 million in milestone-based contingent payments.

| 21/11/2025 | By 238

Moderna Onshores Full mRNA Drug Production to USA, Expands Norwood Facility

Moderna Onshores Full mRNA Drug Production to USA, Expands Norwood Facility

Moderna, Inc. announced a major expansion of its U.S. manufacturing operations by bringing drug product manufacturing to its Moderna Technology Center (MTC) in Norwood, Massachusetts. With this onshoring move, the company will now manage complete end-to-end manufacturing for its mRNA medicines within the United States.

| 21/11/2025 | By 253

Amcor hosts industry discussion on future of logistics packaging ahead of PPWR

Amcor hosts industry discussion on future of logistics packaging ahead of PPWR

Amcor recently convened leading industry stakeholders to discuss the future of logistics packaging in light of the upcoming Packaging and Packaging Waste Regulation (PPWR), focusing on regulatory readiness, innovation-driven transformation, and strengthening responsible supply-chain packaging solutions.

| 21/11/2025 | By 221

Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors

Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors

After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.

| 21/11/2025 | By 215

Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health

Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health

Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.

| 21/11/2025 | By 521

Nadda Urges Pharma Industry to Cut Reliance on Imported APIs

Nadda Urges Pharma Industry to Cut Reliance on Imported APIs

Health Minister Mansukh Mandaviya has called on India’s pharmaceutical industry to reduce dependency on imported active pharmaceutical ingredients (APIs) and focus on strengthening domestic manufacturing capability. He emphasised that enhancing self-reliance in API production is vital for national health security and economic resilience.

| 21/11/2025 | By 256

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members